The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
The Anthrax Vaccine: Is it Safe? Does it Work?
Pittman PR, Sjogren MH, Hack D, Franz D, Makuch RS, Arthur JS. 1997. Serologic Response to Anthrax and Botulinum Vaccines. Protocol No. FY92-5, M109, Log No. A-5747. Final report to the Food and Drug Administration. Fort Detrick, Md.: U.S. Army Medical Research Institute of Infectious Diseases.
Pittman PR, Kim-Ahn G, Pifat DY, Coon K, Gibbs P, Little S, Pace-Templeton J, Myers R, Parker GW, Friedlander AM. 2002. Anthrax vaccine: safety and immunogenicity of a dose-reduction, route comparison study in humans. Vaccine 20(9–10):1412–1420.
Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee KT Jr, Friedlander AM, Sjogren MH. In press. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid. Vaccine.
Puziss M, Manning LC, Lynch JW, Barclay E, Abelow I, Wright GG. 1963. Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures. Applied Microbiology 11(4):330–334.
Rehme P. 2001. Ambulatory medical visits among anthrax-vaccinated and unvaccinated personnel after return from Southwest Asia. Presentation to the Institute of Medicine Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Meeting IV, Washington, D.C.
Rehme PA, Williams R, Grabenstein JD. 2002. Ambulatory medical visits among anthrax-vaccinated and unvaccinated personnel after return from Southwest Asia. Military Medicine 167:205–210.
Robles DT, Eisenbarth GS. 2001. Type 1A diabetes induced by infection and immunization. Journal of Autoimmunity 16(3):355–362.
Ryan M. 2002. Assessment of birth defects among infants of women who received anthrax vaccine: information for the Institute of Medicine, Washington, D.C. Microsoft Power Point slides.
Ryan MA, Pershyn-Kisor MA, Honner WK, Smith TC, Reed RJ, Gray GC. 2001. The Department of Defense Birth Defects Registry: overview of a new surveillance system. Teratology 64(Suppl 1):S26-S29.
Sato PA. 2001a. DoD-wide surveillance of hospitalizations for long-term adverse events potentially associated with anthrax immunization. Presentation to the Institute of Medicine Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Meeting IV, Washington, D.C.
Sato PA. 2001b. Questions on updated data. E-mail to Joellenbeck L, Institute of Medicine, Washington, D.C., November 21.
Sato PA, Reed RJ, Smith TC, Wang LZ. 2001. DoD-wide medical surveillance for potential long-term adverse events associated with anthrax immunization: hospitalizations. Provisional report for IOM of data from January 1998 to March 2000. Unpublished manuscript.
Tanner J. 2001. Survey results of the 9th Airlift Squadron. Presentation to the Joint Meeting of the Institute of Medicine Committee to Assess the Safety and Efficacy of the Anthrax Vaccine and the Institute of Medicine Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Meeting III, Washington, D.C.
Treanor JJ. 2001. Adverse reactions following vaccination of adults. Commissioned paper. Committee to Assess the Safety and Efficacy of the Anthrax Vaccine, Institute of Medicine, Washington, D.C.